Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$5 Bill last 12 months
My fear is the SEC will not figure out that massive short selling was the cause of this and blame someone else. And decide to infringe upon free speech and freedom to pursue property / happiness. (Those terms were interchangeable way back then)
They could sell 2 mill shares and get out of debt. That would not do too much to end the short squeeze
That depends on how stubborn and stupid Wall $treet is.
I suspect that our corporatist government / courts / media will “convict” longs of “conspiring” against “poor unsuspecting Wall Street”. That’s how little trust I have left in the various institutions anymore.
After all, our government is of the money, by the money and for the money ... isn’t it ?
That was before. Sadly, big tech NOW exists to SUPRESS free speech.
Analyst Buzz Lightyear said he projects the share price to go “To infinity and beyond”
I saw on Stock Twits a link to an article that referenced that GALT’s Belapectin *IS* being studied in an animal pre-clinical trial.
They seem to be averse to giving shareholders anything to hope for in the next 12 months. Everything is downplayed; almost got the impression that NASH-RX was being done as a lark. Of course I knew that wasn’t true, but after that CC many months ago ... well, it was depressing. That ceo is gone.
I seriously don’t think they are pursuing Covid at all.
That’s what media *says*. Like in virtually everything else, the atmosphere ain’t as simple as you’d think. The scientists ain’t as one sided as the media says; it’s just the money coming into research is one-sided. Scientists recognize that and won’t say anything to jeopardize their funding from the university. Like many other things lately, there’s only one side of an issue that you can take without ruining your life or career.
They talked about Covid affecting the NASH trial, but nothing about research for GRMD02 treating Covid.
I was wrong. The entire call was NASH-Rx and restating company history.
I inserted a goofy face to indicate that I was just kidding on the last sentence, but it came out as question marks.
I am expecting almost all of the call to be on the NASH 2b/3 trial. I had hoped for some Covid news some time ago, but have given up on that. Covid would have taken away from Shlevin’s golf game, but now that he’s not CEO, that might be a possibility. ??
The former CEO Shlevin announced the 2b/3 trial months ago, and I got the impression that it was done as a lark and the company didn’t expect the trial to do well. Of course I knew that ain’t true, but that’s the tenor / timbre (?) he conveyed at the time.
After about 3 years of “gloom, despair and agony on me” an up day like this is a delight.
Copied from another board :
“Furthermore, we detected about ~3.4x upregulation of LGALS3BP, which is known to induce the expression of IL-6 by stromal cells in Galectin-3-dependent manner (Silverman et al., 2012). Of note, Galectin-3 has long been considered an attractive drug target in combating various forms of TGF-ß-mediated fibrosis and pathological inflammatory conditions (Brinchmann et al., 2018; Mackinnon et al., 2012; Shen et al.,2018; Yu Lili et al., 2013). Inhibition of Galectin-3-mediated signalling pathways hence represents another potential therapeutic target against COVID-19.”
https://www.medrxiv.org/content/10.1101/2020.04.27.20081810v1
About time for another GALT chart, right Clay ?
The company doesn’t talk because there has been NOTHING to talk about for 2 years ! Other than the rights offering and a couple of patents.
So minus cash the “value” of the company is only $50 Mill. Wow.
<tap tap> Is this thing on ?
Impressive ! https://stockcharts.com/h-sc/ui?s=CYDY
Yes, thank you very much
Company just got $87 Mill, but the mkt cap failed to go up even half of that amount. Why ?
Oh, I see you were joking.
$12-$60 Bill ? Nonsense. Be lucky to get $1.2 Bill.
Once the correct number of patients reach 1 year or so, there will not be much down time while results are compiled. But FDA will require much too long to “think about it”. This was expected to take 3 years anyway. 1 or 2 qtrs of trial length added unfortunately.
I think they are “too small to succeed”
I didn’t see another study for dosing. Just a confirmation of dosing. They still say first patient will be dosed in Q1. So you’re saying the trial will last 6-8 months longer. Traber is still forking the company over long after he’s gone.
FDA = Forking Delayed Again
Yeah, why would they agree to this BEFORE the phase 3 was set ?
That’s exactly what I thought. That’s exactly what I expect given my investment results.
Sorry, 95 on Saturday.
85, 90 ... We have 85, 90 on Saturday ....
80 days, do I hear 85 days ? Going once ...
Was today’s rise merely short covering, you think ?
GALT doesn’t care whether we know about this or not.
Is no one interested ? It appears that way.
75 days would be .... tomorrow ? Sweet dreams.